Liver transplantation for acute liver failure – a 30-year single center experience

<p><b>Objective:</b> To determine overall long-term patient and graft survival rates among the recipients liver transplanted due to acute liver failure (ALF). Secondary aims included assessment of whether diagnosis, donor-recipient blood group compatibility and time-era of transplantation affected the outcome, and whether prescription-free availability of acetaminophen increased the need for liver transplantation (LTx).</p> <p><b>Materials and Methods:</b> A Retrospective cohort study of 78 patients who underwent LTx for ALF at Karolinska University Hospital 1984–2014. Patients were divided into two cohorts according to two 15-year periods: early cohort transplanted 1984–1999 (<i>n</i> = 40) and late cohort transplanted 2000–2014 (<i>n</i> = 38). Survival rates were established using Kaplan-Meier analyses.</p> <p><b>Results:</b> ALF patient survival rates for 1-year, 5-years, 10-years and 20-years were 71%, 63%, 52% and 40%, respectively. Survival for the late cohort at 1, 5 and 10 years was 82%, 76% and 71%, respectively. A high early mortality rate was noted during the first three months after transplantation when compared to LTx patients with chronic disease. Long-term survival rates were comparable between patients with ALF and chronic liver disease. Prescription-free access to acetaminophen did not increase the need for LTx. There was a strong trend towards improved survival in blood group identical donor-recipient pairs and blood group O recipients may have benefitted from this.</p> <p><b>Conclusions:</b> The high early mortality rate most likely reflects the critical pre-transplant condition in these patients and the urgent need to sometimes accept a marginal donor liver. Long-term survival improved significantly over time and variation in patient access to acetaminophen did not influence the rate of LTx in our region.</p